Aryl ureido derivatives and their medical use
CA 2502705 A1 · Owner: Valgeirsson, Jon · Inventors: Valgeirsson, Jon; Peters, Dan; Nielsen, Elsebet Ostergaard
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
This invention relates to novel aryl ureido benzoic acid derivatives useful as selective and non-competitive antagonists of the ionotropic GluR5 receptor. Due to their biological activity, the aryl ureido derivatives of the invention are considered useful for treating diseases that are responsive to modulation of an aspartate or a glutamate receptor. Moreover the invention provides chemical compounds for use according to the invention as well as , pharmaceutical compositions comprising the chemical compounds and methods of , treating diseases or disorders or conditions responsive to modulation of an aspartate or a glutamate receptor.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed November 10, 2003. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended November 10, 2023.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by November 10, 2025.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.